Awa, Stewie B.
HRN: 20-92-60 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/18/2022
05/24/2022
IV
400mg
Q6h
PCAP C With HRAD
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes